Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland
Transfusion · 2024
DOI: 10.1111/trf.17700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Sanna Susila und 5 weiteren Autor:innen. Beteiligte Einrichtung: Finnish Red Cross Blood Service, Vantaa, Finland. Hauptthemen laut MEDLINE: ABO Blood-Group System, Rh Isoimmunization. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Prehospital low‐titer group O whole blood (LTOWB) used for patients with life‐threatening hemorrhage is often RhD positive. The most important complication following RhD alloimmunization is hemolytic disease of the fetus and newborn (HDFN). Preceding clinical use of RhD positive LTOWB, we estimated the risk of HDFN due to LTOWB prehospital transfusion in the Finnish population. Study Design and Methods We collected data on prehospital transfusions in Tampere and Helsinki University Hospital areas. Using the mean of reported alloimmunization rates in trauma studies (24%) and a higher reported rate representing trauma patients of 13–50 years old (42.7%), we estimated the risk of HDFN and extrapolated it to the whole of Finland.
Results
We estimated that in Finland, with the current prehospital transfusion rate we would see 1–3 cases of severe HDFN due to prehospital LTOWB transfusions every 10 years, and fetal death due to HDFN caused by LTOWB transfusion less than once in 100 years.
Discussion
The estimated risk of serious HDFN due to prehospital LTOWB transfusion in the Finnish population is similar to previous estimates. As Finland routinely screens expectant mothers for red blood cell antibodies and as the contemporary treatment of HDFN is very effective, we support the prehospital use of RhD positive LTOWB in all patient groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Finnish Red Cross Blood Service, Vantaa, Finland.
- Emergency Medical Service and Emergency Department, Päijät-Häme wellbeing services county, Lahti, Finland.
- Department of Anesthesiology and Intensive Care Medicine, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Meilahti Hospital Blood Bank, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Emergency Medical Services, Centre for Prehospital Emergency Care, Pirkanmaa wellbeing services county, Tampere, Finland.
- Department of Emergency Medicine and Services, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
ORCID-Profile: Sanna Susila, Minna Ilmakunnas
Zitieren
APA
Susila, S., Ilmakunnas, M., Lauronen, J., Vuorinen, P., Ångerman, S., & Sainio, S. (2024). Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland. Transfusion. https://doi.org/10.1111/trf.17700
Vancouver
Susila S, Ilmakunnas M, Lauronen J, Vuorinen P, Ångerman S, Sainio S. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland. Transfusion. 2024. doi:10.1111/trf.17700
BibTeX
@article{Susila2024,
author = {Susila, Sanna and Ilmakunnas, Minna and Lauronen, Jouni and Vuorinen, Pauli and Ångerman, Susanne and Sainio, Susanna},
title = {Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17700}
}
EUVIMED